Want help reviewing this study?
Study ID: ISRCTN67429289. We help you review the study, but cannot decide medical eligibility.
RecruitingISRCTN67429289
A peer support programme to help adults with psychosis talk about mental health and reduce stigma
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
Schizophrenia, Mental healthOtherFrom 16 Years to 100 Years
Understand this study
Who could participate?
Listed age limits: 16 years to 100 years.
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Greater Manchester Mental Health NHS Foundation Trust
- Sponsor type
- Non-profit organization
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 16 Years to 100 Years
- Official registry ID
- ISRCTN67429289
- Official title
- A peer support programme to help adults with psychosis talk about mental health and reduce stigma
Recruitment & locations
RecruitingUnited Kingdom
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Greater Manchester Mental Health NHS Foundation Trust.
Who can participate?
Listed age limits: 16 years to 100 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
RecruitingISRCTN83479057
A clinical study to investigate whether third-line treatments work better as a second-line treatment for people diagnosed with schizophrenia
The registry lists this study as recruiting. Study locations are listed in Australia, in the United Kingdom, in Austria, ... Confirm recruitment at each site. It focuses on schizophrenia.
RecruitingISRCTN79796233
A study to investigate how effective a stimulant medication is compared to a non-stimulant medication in patients who have been diagnosed with attention deficit hyperactivity disorder (ADHD) and also have a history of either psychosis or Bipolarity
The registry lists this study as recruiting. Study locations are listed in the United Kingdom. Confirm recruitment at each site. It focuses on ADHD.
RecruitingISRCTN47913690
A study looking at whether metformin (a diabetes drug) can prevent weight gain caused by antipsychotics in people experiencing their first episode of psychosis
The registry lists this study as recruiting. Study locations are listed in the United Kingdom. Confirm recruitment at each site. It focuses on Schizophrenia.